{"count":220751,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=2006","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=2004","results":[{"created":"2020-01-04T11:49:58.443507+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.117","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: STXBP1 was changed from BOTH monoallelic and biallelic, autosomal or pseudoautosomal to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"STXBP1","entity_type":"gene"},{"created":"2020-01-04T11:49:30.668786+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.117","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: STXBP1 was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"STXBP1","entity_type":"gene"},{"created":"2020-01-04T11:48:51.473869+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.116","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: STXBP1: Rating: GREEN; Mode of pathogenicity: Other; Publications: 31855252; Phenotypes: Epileptic encephalopathy, early infantile, 4, MIM#612164; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"STXBP1","entity_type":"gene"},{"created":"2020-01-04T11:44:42.285582+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.116","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ABAT as ready","entity_name":"ABAT","entity_type":"gene"},{"created":"2020-01-04T11:44:42.279998+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.116","user_name":"Zornitza Stark","item_type":"entity","text":"Added comment: Comment when marking as ready: Seizures are a prominent part of the phenotype, EEGs show burst-suppression, modified hypsarrhythmia, multifocal spikes, and generalized spike-wave.","entity_name":"ABAT","entity_type":"gene"},{"created":"2020-01-04T11:44:42.246606+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.116","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: abat has been classified as Green List (High Evidence).","entity_name":"ABAT","entity_type":"gene"},{"created":"2020-01-04T11:44:28.571137+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.116","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ABAT were changed from  to GABA-transaminase deficiency, MIM#613163","entity_name":"ABAT","entity_type":"gene"},{"created":"2020-01-04T11:43:55.916413+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.115","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: ABAT were set to ","entity_name":"ABAT","entity_type":"gene"},{"created":"2020-01-04T11:42:29.943562+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.114","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: ABAT was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"ABAT","entity_type":"gene"},{"created":"2020-01-04T11:40:39.726933+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.618","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ADRA2B as ready","entity_name":"ADRA2B","entity_type":"gene"},{"created":"2020-01-04T11:40:39.721369+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.618","user_name":"Zornitza Stark","item_type":"entity","text":"Added comment: Comment when marking as ready: Comment when marking as ready: Association has in fact been REFUTED by Corbett et al 2019 (PMID:31664034, who identified an alternative cause in the original families.","entity_name":"ADRA2B","entity_type":"gene"},{"created":"2020-01-04T11:40:39.690737+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.618","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: adra2b has been classified as Red List (Low Evidence).","entity_name":"ADRA2B","entity_type":"gene"},{"created":"2020-01-04T11:39:48.373831+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.618","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: ADRA2B were set to ","entity_name":"ADRA2B","entity_type":"gene"},{"created":"2020-01-04T11:38:28.528837+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.617","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ADRA2B as Red List (low evidence)","entity_name":"ADRA2B","entity_type":"gene"},{"created":"2020-01-04T11:38:28.516278+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.617","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: adra2b has been classified as Red List (Low Evidence).","entity_name":"ADRA2B","entity_type":"gene"},{"created":"2020-01-04T11:37:55.866844+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.113","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ADRA2B as ready","entity_name":"ADRA2B","entity_type":"gene"},{"created":"2020-01-04T11:37:55.861263+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.113","user_name":"Zornitza Stark","item_type":"entity","text":"Added comment: Comment when marking as ready: Association has in fact been REFUTED by Corbett et al 2019, who identified an alternative cause in the original families.","entity_name":"ADRA2B","entity_type":"gene"},{"created":"2020-01-04T11:37:55.828882+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.113","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: adra2b has been classified as Red List (Low Evidence).","entity_name":"ADRA2B","entity_type":"gene"},{"created":"2020-01-04T11:37:52.066314+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.113","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ADRA2B were changed from  to Cortical myoclonus and epilepsy","entity_name":"ADRA2B","entity_type":"gene"},{"created":"2020-01-04T11:37:21.756095+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.112","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: ADRA2B were set to ","entity_name":"ADRA2B","entity_type":"gene"},{"created":"2020-01-04T11:36:18.636693+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.111","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ADRA2B as Red List (low evidence)","entity_name":"ADRA2B","entity_type":"gene"},{"created":"2020-01-04T11:36:18.624019+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.111","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: adra2b has been classified as Red List (Low Evidence).","entity_name":"ADRA2B","entity_type":"gene"},{"created":"2020-01-04T11:35:00.346224+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.110","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ADRA2B as Amber List (moderate evidence)","entity_name":"ADRA2B","entity_type":"gene"},{"created":"2020-01-04T11:35:00.330738+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.110","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: adra2b has been classified as Amber List (Moderate Evidence).","entity_name":"ADRA2B","entity_type":"gene"},{"created":"2020-01-04T09:18:08.143531+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.616","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: AGO3 as ready","entity_name":"AGO3","entity_type":"gene"},{"created":"2020-01-04T09:18:08.127288+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.616","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ago3 has been classified as Red List (Low Evidence).","entity_name":"AGO3","entity_type":"gene"},{"created":"2020-01-04T09:17:45.941453+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.616","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: AGO3 were changed from Intellectual disability; epilepsy; structural brain malformations to Intellectual disability","entity_name":"AGO3","entity_type":"gene"},{"created":"2020-01-04T09:17:16.476386+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.615","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: AGO3 as ready","entity_name":"AGO3","entity_type":"gene"},{"created":"2020-01-04T09:17:16.464800+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.615","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ago3 has been classified as Red List (Low Evidence).","entity_name":"AGO3","entity_type":"gene"},{"created":"2020-01-04T09:17:05.729117+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.615","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: AGO3 were changed from  to Intellectual disability; epilepsy; structural brain malformations","entity_name":"AGO3","entity_type":"gene"},{"created":"2020-01-04T09:16:50.540081+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.614","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: AGO3 were set to ","entity_name":"AGO3","entity_type":"gene"},{"created":"2020-01-04T09:16:36.104905+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.613","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: AGO3 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"AGO3","entity_type":"gene"},{"created":"2020-01-04T09:16:03.503811+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.612","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: AGO3 as Red List (low evidence)","entity_name":"AGO3","entity_type":"gene"},{"created":"2020-01-04T09:16:03.490950+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.612","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ago3 has been classified as Red List (Low Evidence).","entity_name":"AGO3","entity_type":"gene"},{"created":"2020-01-04T09:15:33.220926+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.109","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: AGO3 as ready","entity_name":"AGO3","entity_type":"gene"},{"created":"2020-01-04T09:15:33.208567+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.109","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ago3 has been classified as Red List (Low Evidence).","entity_name":"AGO3","entity_type":"gene"},{"created":"2020-01-04T09:15:28.775948+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.109","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: AGO3 were changed from  to Intellectual disability","entity_name":"AGO3","entity_type":"gene"},{"created":"2020-01-04T09:14:56.981291+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.108","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: AGO3 were set to ","entity_name":"AGO3","entity_type":"gene"},{"created":"2020-01-04T09:14:18.729518+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.107","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: AGO3 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"AGO3","entity_type":"gene"},{"created":"2020-01-04T09:13:48.161194+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.106","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: AGO3 as Red List (low evidence)","entity_name":"AGO3","entity_type":"gene"},{"created":"2020-01-04T09:13:48.143829+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.106","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ago3 has been classified as Red List (Low Evidence).","entity_name":"AGO3","entity_type":"gene"},{"created":"2020-01-04T09:12:27.797997+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.105","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ASTN1 were changed from Intellectual disability; epilepsy; structural brain malformations to Intellectual disability; epilepsy; structural brain malformations","entity_name":"ASTN1","entity_type":"gene"},{"created":"2020-01-04T09:12:25.371155+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.105","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ASTN1 as ready","entity_name":"ASTN1","entity_type":"gene"},{"created":"2020-01-04T09:12:25.358537+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.105","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: astn1 has been classified as Green List (High Evidence).","entity_name":"ASTN1","entity_type":"gene"},{"created":"2020-01-04T09:12:00.959404+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.105","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ASTN1 were changed from  to Intellectual disability; epilepsy; structural brain malformations","entity_name":"ASTN1","entity_type":"gene"},{"created":"2020-01-04T09:10:43.421769+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.104","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: ASTN1 were set to ","entity_name":"ASTN1","entity_type":"gene"},{"created":"2020-01-04T09:10:07.988569+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.103","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: ASTN1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"ASTN1","entity_type":"gene"},{"created":"2020-01-04T09:09:08.266459+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.102","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: BRAT1 were changed from Neurodevelopmental disorder with cerebellar atrophy and with or without seizures, MIM#618056 to Neurodevelopmental disorder with cerebellar atrophy and with or without seizures, MIM#618056","entity_name":"BRAT1","entity_type":"gene"},{"created":"2020-01-04T09:09:03.449196+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.102","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: BRAT1 as ready","entity_name":"BRAT1","entity_type":"gene"},{"created":"2020-01-04T09:09:03.433328+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.102","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: brat1 has been classified as Green List (High Evidence).","entity_name":"BRAT1","entity_type":"gene"},{"created":"2020-01-04T09:08:41.047561+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.102","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: BRAT1 were changed from  to Neurodevelopmental disorder with cerebellar atrophy and with or without seizures, MIM#618056","entity_name":"BRAT1","entity_type":"gene"},{"created":"2020-01-04T09:07:05.404505+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.101","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: BRAT1 were set to ","entity_name":"BRAT1","entity_type":"gene"},{"created":"2020-01-04T09:06:33.316548+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.100","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: BRAT1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"BRAT1","entity_type":"gene"},{"created":"2020-01-04T09:05:30.689339+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.99","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DMXL2 as ready","entity_name":"DMXL2","entity_type":"gene"},{"created":"2020-01-04T09:05:30.677045+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.99","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dmxl2 has been classified as Green List (High Evidence).","entity_name":"DMXL2","entity_type":"gene"},{"created":"2020-01-04T09:04:57.993463+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.99","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MED17 as ready","entity_name":"MED17","entity_type":"gene"},{"created":"2020-01-04T09:04:57.981769+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.99","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: med17 has been classified as Green List (High Evidence).","entity_name":"MED17","entity_type":"gene"},{"created":"2020-01-04T09:04:48.837970+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.99","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MED17 were changed from  to Microcephaly, postnatal progressive, with seizures and brain atrophy, MIM#613668","entity_name":"MED17","entity_type":"gene"},{"created":"2020-01-04T09:03:53.305221+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.98","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: MED17 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"MED17","entity_type":"gene"},{"created":"2020-01-04T09:02:50.254572+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.97","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: MED17 were set to ","entity_name":"MED17","entity_type":"gene"},{"created":"2020-01-04T09:01:40.375844+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.96","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PIGG as ready","entity_name":"PIGG","entity_type":"gene"},{"created":"2020-01-04T09:01:40.362325+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.96","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pigg has been classified as Green List (High Evidence).","entity_name":"PIGG","entity_type":"gene"},{"created":"2020-01-04T09:01:30.256510+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.96","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: PIGG were changed from  to Mental retardation, autosomal recessive 53, MIM#616917","entity_name":"PIGG","entity_type":"gene"},{"created":"2020-01-04T09:00:51.321572+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.95","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: PIGG were set to ","entity_name":"PIGG","entity_type":"gene"},{"created":"2020-01-04T09:00:15.482469+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.94","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: PIGG was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"PIGG","entity_type":"gene"},{"created":"2020-01-04T08:59:19.536046+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.93","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TBCD as ready","entity_name":"TBCD","entity_type":"gene"},{"created":"2020-01-04T08:59:19.521395+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.93","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tbcd has been classified as Green List (High Evidence).","entity_name":"TBCD","entity_type":"gene"},{"created":"2020-01-04T08:59:13.942883+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.93","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: TBCD were changed from  to Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum, MIM#617193","entity_name":"TBCD","entity_type":"gene"},{"created":"2020-01-04T08:58:36.629025+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.92","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: TBCD were set to ","entity_name":"TBCD","entity_type":"gene"},{"created":"2020-01-04T08:57:58.905481+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.91","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: TBCD was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"TBCD","entity_type":"gene"},{"created":"2020-01-04T08:56:56.472235+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.90","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ADAM22 as ready","entity_name":"ADAM22","entity_type":"gene"},{"created":"2020-01-04T08:56:56.457645+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.90","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: adam22 has been classified as Amber List (Moderate Evidence).","entity_name":"ADAM22","entity_type":"gene"},{"created":"2020-01-04T08:55:20.091580+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.611","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PIGP as ready","entity_name":"PIGP","entity_type":"gene"},{"created":"2020-01-04T08:55:20.080836+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.611","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pigp has been classified as Amber List (Moderate Evidence).","entity_name":"PIGP","entity_type":"gene"},{"created":"2020-01-04T08:55:09.935020+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.611","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: PIGP as Amber List (moderate evidence)","entity_name":"PIGP","entity_type":"gene"},{"created":"2020-01-04T08:55:09.922755+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.611","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pigp has been classified as Amber List (Moderate Evidence).","entity_name":"PIGP","entity_type":"gene"},{"created":"2020-01-04T08:54:50.599641+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.610","user_name":"Zornitza Stark","item_type":"entity","text":"gene: PIGP was added\ngene: PIGP was added to Mendeliome_VCGS. Sources: Expert list\nMode of inheritance for gene: PIGP was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: PIGP were set to 31139695\nPhenotypes for gene: PIGP were set to Epileptic encephalopathy, early infantile, 55, MIM#\t617599\nReview for gene: PIGP was set to AMBER\nAdded comment: Three individuals from two unrelated families reported. \nSources: Expert list","entity_name":"PIGP","entity_type":"gene"},{"created":"2020-01-04T08:53:08.877131+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.90","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PIGP as ready","entity_name":"PIGP","entity_type":"gene"},{"created":"2020-01-04T08:53:08.866493+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.90","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pigp has been classified as Amber List (Moderate Evidence).","entity_name":"PIGP","entity_type":"gene"},{"created":"2020-01-04T08:53:02.329209+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.90","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: PIGP as Amber List (moderate evidence)","entity_name":"PIGP","entity_type":"gene"},{"created":"2020-01-04T08:53:02.316679+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.90","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pigp has been classified as Amber List (Moderate Evidence).","entity_name":"PIGP","entity_type":"gene"},{"created":"2020-01-04T08:52:24.968843+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.89","user_name":"Zornitza Stark","item_type":"entity","text":"gene: PIGP was added\ngene: PIGP was added to Genetic Epilepsy_AustralianGenomics_VCGS. Sources: Expert list\nMode of inheritance for gene: PIGP was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: PIGP were set to 28334793; 31139695\nPhenotypes for gene: PIGP were set to Epileptic encephalopathy, early infantile, 55, MIM#\t617599\nReview for gene: PIGP was set to AMBER\nAdded comment: Three individuals from two unrelated families reported. \nSources: Expert list","entity_name":"PIGP","entity_type":"gene"},{"created":"2020-01-04T08:47:42.504363+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.609","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NEUROD2 as ready","entity_name":"NEUROD2","entity_type":"gene"},{"created":"2020-01-04T08:47:42.493590+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.609","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: neurod2 has been classified as Green List (High Evidence).","entity_name":"NEUROD2","entity_type":"gene"},{"created":"2020-01-04T08:47:29.383741+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.609","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NEUROD2 as Green List (high evidence)","entity_name":"NEUROD2","entity_type":"gene"},{"created":"2020-01-04T08:47:29.370734+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.609","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: neurod2 has been classified as Green List (High Evidence).","entity_name":"NEUROD2","entity_type":"gene"},{"created":"2020-01-04T08:47:07.005649+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.608","user_name":"Zornitza Stark","item_type":"entity","text":"gene: NEUROD2 was added\ngene: NEUROD2 was added to Mendeliome_VCGS. Sources: Expert list\nMode of inheritance for gene: NEUROD2 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted\nPublications for gene: NEUROD2 were set to 30323019\nPhenotypes for gene: NEUROD2 were set to Epileptic encephalopathy, early infantile, 72, MIM#\t618374\nReview for gene: NEUROD2 was set to GREEN\nAdded comment: Two unrelated individuals with de novo missense variants in this gene, animal model. \nSources: Expert list","entity_name":"NEUROD2","entity_type":"gene"},{"created":"2020-01-04T08:45:20.346205+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.88","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NEUROD2 as ready","entity_name":"NEUROD2","entity_type":"gene"},{"created":"2020-01-04T08:45:20.334793+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.88","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: neurod2 has been classified as Green List (High Evidence).","entity_name":"NEUROD2","entity_type":"gene"},{"created":"2020-01-04T08:45:15.855028+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.88","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NEUROD2 as Green List (high evidence)","entity_name":"NEUROD2","entity_type":"gene"},{"created":"2020-01-04T08:45:15.841988+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.88","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: neurod2 has been classified as Green List (High Evidence).","entity_name":"NEUROD2","entity_type":"gene"},{"created":"2020-01-04T08:44:39.601366+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.87","user_name":"Zornitza Stark","item_type":"entity","text":"gene: NEUROD2 was added\ngene: NEUROD2 was added to Genetic Epilepsy_AustralianGenomics_VCGS. Sources: Expert list\nMode of inheritance for gene: NEUROD2 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted\nPublications for gene: NEUROD2 were set to 30323019\nPhenotypes for gene: NEUROD2 were set to Epileptic encephalopathy, early infantile, 72, MIM#\t618374\nReview for gene: NEUROD2 was set to GREEN\nAdded comment: Two unrelated individuals with de novo missense variants in this gene, animal model. \nSources: Expert list","entity_name":"NEUROD2","entity_type":"gene"},{"created":"2020-01-04T08:40:51.705539+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.607","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GOT2 as ready","entity_name":"GOT2","entity_type":"gene"},{"created":"2020-01-04T08:40:51.693642+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.607","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: got2 has been classified as Green List (High Evidence).","entity_name":"GOT2","entity_type":"gene"},{"created":"2020-01-04T08:40:41.775267+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.607","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: GOT2 as Green List (high evidence)","entity_name":"GOT2","entity_type":"gene"},{"created":"2020-01-04T08:40:41.763290+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.607","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: got2 has been classified as Green List (High Evidence).","entity_name":"GOT2","entity_type":"gene"},{"created":"2020-01-04T08:40:21.395315+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.606","user_name":"Zornitza Stark","item_type":"entity","text":"gene: GOT2 was added\ngene: GOT2 was added to Mendeliome_VCGS. Sources: Expert list\nMode of inheritance for gene: GOT2 was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: GOT2 were set to 31422819\nPhenotypes for gene: GOT2 were set to Epileptic encephalopathy, early infantile, 82, MIM#\t618721\nReview for gene: GOT2 was set to GREEN\nAdded comment: Four individuals from three unrelated families reported. Treatment with pyridoxine and serine ameliorated the phenotype. \nSources: Expert list","entity_name":"GOT2","entity_type":"gene"},{"created":"2020-01-04T08:38:23.474097+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.86","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GOT2 as ready","entity_name":"GOT2","entity_type":"gene"},{"created":"2020-01-04T08:38:23.463413+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.86","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: got2 has been classified as Green List (High Evidence).","entity_name":"GOT2","entity_type":"gene"},{"created":"2020-01-04T08:38:17.901030+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.86","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: GOT2 as Green List (high evidence)","entity_name":"GOT2","entity_type":"gene"}]}